A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer

被引：12
|
作者：
El-Ashmawy, Nahla E. [1 ]
Khalil, Rania M. [2 ]
机构：
[1] Tanta Univ, Dept Biochem, Fac Pharm, Tanta, Egypt
[2] Delta Univ, Dept Biochem, Fac Pharm, Gamasah, Egypt
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 04期
关键词：
Breast cancer; Cancer prognosis; L-carnitine; Resistance; Side effects; Tamoxifen; ACETYL-L-CARNITINE; RANDOMIZED DOUBLE-BLIND; PROPIONYL-L-CARNITINE; FATTY-ACID SYNTHASE; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; DEPRESSED MOOD; HUMAN CORNEAL; FATIGUE;
D O I：
10.1007/s13277-013-1477-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
l-carnitine is an antioxidant and is found to be a protective agent against many diseases including cancer. This review illustrates the possible role of l-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen. The objectives of carnitine treatment are diverse: improving tamoxifen-related side effects, offering better cancer prognosis by reducing the risk of developing cancer recurrence or metastasis, and modulating the growth factors which may be, in part, a prospective illustration to overcome tamoxifen resistance. So, it could be recommended to supplement l-carnitine to breast cancer patients starting tamoxifen treatment.
引用
收藏
页码：2845 / 2855
页数：11
相关论文
共 50 条
  • [21] Effects of Tamoxifen on the Cervix and Uterus in Women with Breast Cancer: Experience with Iranian Patients and a Literature Review
    Zarchi, Mojgan Karimi
    Behtash, Nadereh
    Sekhavat, Leila
    Dehghan, Atefeh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (04) : 595 - 598
  • [22] Tamoxifen and contralateral breast cancer: the other side
    Swain, SM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (13) : 963 - 965
  • [23] Effects of tamoxifen on benign breast disease in women at high risk for breast cancer
    Tan-Chiu, E
    Wang, JP
    Costantino, JP
    Paik, S
    Butch, C
    Wickerham, DL
    Fisher, B
    Wolmark, N
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 302 - 307
  • [24] GYNECOLOGIC TUMORS IN TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER - REPLY
    WEED, JC
    OBSTETRICS AND GYNECOLOGY, 1994, 83 (01): : 158 - 159
  • [25] Sonographic and Hysteroscopic Surveillance in Women with Breast Cancer Treated with Tamoxifen: A Retrospective Study
    Tsonis, O.
    Gkrozou, F.
    Dimitriou, E.
    Igbokwe, N.
    Mohamed, M.
    Vatopoulou, A.
    Paschopoulos, M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (04)
  • [26] Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    Uziely, B
    Lewin, A
    MorYosef, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 141 - 144
  • [27] Sonographic and Hysteroscopic Surveillance in Women with Breast Cancer Treated with Tamoxifen: A Retrospective Study
    O. Tsonis
    F. Gkrozou
    E. Dimitriou
    Ν. Igbokwe
    M. Mohamed
    A. Vatopoulou
    M. Paschopoulos
    Indian Journal of Gynecologic Oncology, 2022, 20
  • [28] Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen
    McCaskill-Stevens, W
    Wilson, J
    Bryant, J
    Mamounas, E
    Garvey, L
    James, J
    Cronin, W
    Wickerham, DL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23): : 1762 - 1769
  • [29] Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    MorYosef, S
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 52 (03) : 249 - 253
  • [30] Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen
    KalefEzra, JA
    Pavlidis, N
    Klouvas, G
    Karantanas, A
    Hatzikonstantinou, I
    Glaros, D
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (02) : 161 - 168
12345